QurieGen

QurieGen operates a closed-loop engine that combines high-throughput single-cell multi-omic technologies with AI-driven virtual cell modeling. The platform utilizes proprietary QuRIE-seq technology and soft perturbation assays to generate temporal, multi-dimensional data for predicting cellular responses and identifying novel drug targets. The company serves the pharmaceutical and biotechnology industries by providing mechanistic insights into disease processes and simulating drug mode-of-action in silico.